Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

84 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Santala M. Santala S, et al. Among authors: santala m. Tumour Biol. 2015 Feb;36(2):953-7. doi: 10.1007/s13277-014-2676-4. Epub 2014 Oct 15. Tumour Biol. 2015. PMID: 25315186
Cyclin B acts as an activator to cyclin-dependent kinase 1 (CDK1), a protein kinase essential for G2/M phase transition. Deregulation of cyclins has been linked to a number of malignant neoplasms, but the impact on clinicopathological parameters seems to be cancer-specific …
Cyclin B acts as an activator to cyclin-dependent kinase 1 (CDK1), a protein kinase essential for G2/M phase transition. Deregulation …
Feasibility of endometrial assessment after thermal ablation.
Ahonkallio SJ, Liakka AK, Martikainen HK, Santala MJ. Ahonkallio SJ, et al. Among authors: santala mj. Eur J Obstet Gynecol Reprod Biol. 2009 Nov;147(1):69-71. doi: 10.1016/j.ejogrb.2009.06.014. Epub 2009 Jul 16. Eur J Obstet Gynecol Reprod Biol. 2009. PMID: 19615812
Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma.
Honkavuori-Toivola M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A. Honkavuori-Toivola M, et al. Among authors: santala m. Dis Markers. 2013;35(4):261-6. doi: 10.1155/2013/416870. Dis Markers. 2013. PMID: 24344400 Free PMC article.
VEGF and its receptors (flt-1 and KDR/flk-1) as prognostic indicators in endometrial carcinoma.
Talvensaari-Mattila A, Soini Y, Santala M. Talvensaari-Mattila A, et al. Among authors: santala m. Tumour Biol. 2005 Mar-Apr;26(2):81-7. doi: 10.1159/000085589. Epub 2005 May 3. Tumour Biol. 2005. PMID: 15867479
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Määttä M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A. Määttä M, et al. Among authors: santala m. Acta Obstet Gynecol Scand. 2010 Mar;89(3):380-4. doi: 10.3109/00016340903555990. Acta Obstet Gynecol Scand. 2010. PMID: 20109015
High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Honkavuori-Toivola M, Santala M. Santala S, et al. Among authors: santala m. Tumour Biol. 2014 Jun;35(6):5395-9. doi: 10.1007/s13277-014-1703-9. Epub 2014 Feb 12. Tumour Biol. 2014. PMID: 24519066
Cyclin A is involved in the transitions between G1 to S and G2 to M. Its deregulation has been linked to a number of neoplasms, including endometrial cancer. ...
Cyclin A is involved in the transitions between G1 to S and G2 to M. Its deregulation has been linked to a number of neoplasms, inclu …
Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma.
Honkavuori-Toivola M, Talvensaari-Mattila A, Soini Y, Turpeenniemi-Hujanen T, Santala M. Honkavuori-Toivola M, et al. Among authors: santala m. Tumour Biol. 2012 Aug;33(4):935-41. doi: 10.1007/s13277-012-0321-7. Epub 2012 Jan 21. Tumour Biol. 2012. PMID: 22270451
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Honkavuori M, Talvensaari-Mattila A, Puistola U, Turpeenniemi-Hujanen T, Santala M. Honkavuori M, et al. Among authors: santala m. Anticancer Res. 2008 Sep-Oct;28(5A):2715-9. Anticancer Res. 2008. PMID: 19035300
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
Määtta M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Santala M. Määtta M, et al. Among authors: santala m. Anticancer Res. 2007 Jul-Aug;27(4C):2753-8. Anticancer Res. 2007. PMID: 17695443
Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
Talvensaari-Mattila A, Santala M, Soini Y, Turpeenniemi-Hujanen T. Talvensaari-Mattila A, et al. Among authors: santala m. Anticancer Res. 2005 Nov-Dec;25(6B):4101-5. Anticancer Res. 2005. PMID: 16309203
84 results
Jump to page
Feedback